Bunnage Mark E. sold VRTX
May 15, 2026 · Form 4 insider transaction
Bunnage Mark E. sold 33 shares of Vertex Pharmaceuticals Incorporated at $453.45 per share, a transaction worth $15.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
33
Price
$453.45
Total value
$15.0K
InsiderBunnage Mark E.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after7,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.